HeHealth is a San Francisco-based Digital Health Startup with a focus on revolutionizing men's sexual health at the population level through the use of AI. Their slogan "Revolutionizing men's sexual health at population level with AI" reflects their commitment to leveraging artificial intelligence (AI) to screen for infectious diseases, including Mpox, in a scalable, accessible, and stigma-free manner.
The company, which was founded in 2022, recently secured a SGD1.00M Seed Round investment on 01 August 2023 from ARKRAY Corporate Venture Capital. This investment will play a crucial role in furthering HeHealth's mission of offering personalized and effective care for STI and Mpox screening. With offices in Singapore and Sri Lanka, HeHealth is strategically positioned to address the neglected health challenges in the realm of men's sexual health on a global scale.
By harnessing the power of AI to provide cost-effective solutions for disease screening, HeHealth is poised to make a significant impact in the AI, Health Care, and Machine Learning industries. With the support of investors like ARKRAY Corporate Venture Capital, HeHealth is well-positioned to lead the way in transforming the landscape of men's sexual health.